AVITA Medical, Inc. – NASDAQ:RCEL
AVITA Medical stock price today
$4.94
-8.55
-63.38%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 7 hours
AVITA Medical stock price monthly change
+44.12%
month
AVITA Medical stock price quarterly change
+44.12%
quarter
AVITA Medical stock price yearly change
-7.41%
year
AVITA Medical key metrics
Market Cap | 306.22M |
Enterprise value | 342.89M |
P/E | -14.33 |
EV/Sales | 6.81 |
EV/EBITDA | -8.21 |
Price/Sales | 7.17 |
Price/Book | 4.25 |
PEG ratio | 16.76 |
EPS | -2.01 |
Revenue | 58.87M |
EBITDA | -53.73M |
Income | -50.79M |
Revenue Q/Q | 49.31% |
Revenue Y/Y | 35.98% |
Profit margin | -84.28% |
Oper. margin | -92.59% |
Gross margin | 81.7% |
EBIT margin | -92.59% |
EBITDA margin | -91.27% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAVITA Medical stock price history
AVITA Medical stock forecast
AVITA Medical financial statements
| Dec 2022 | 9.45M | -7.86M | -83.16% |
|---|---|---|---|
| Mar 2023 | 10.55M | -13.79M | -130.72% |
| Jun 2023 | 17.64M | -15.59M | -88.35% |
| Sep 2023 | 21.22M | -13.55M | -63.85% |
| Jun 2023 | 17.64M | -15.59M | -88.35% |
|---|---|---|---|
| Sep 2023 | 21.22M | -13.55M | -63.85% |
| Sep 2025 | 29.4M | -8.77M | -29.83% |
| Dec 2025 | 36.65M | -6.41M | -17.5% |
Analysts Price target
Financials & Ratios estimates
| 2022-11-10 | -0.34 | -0.22 |
|---|
| Dec 2022 | 98264000 | 13.52M | 13.76% |
|---|---|---|---|
| Mar 2023 | 138543987 | 22.52M | 16.26% |
| Jun 2023 | 129615862 | 26.54M | 20.48% |
| Sep 2023 | 126025378 | 28.05M | 22.26% |
| Dec 2022 | -5.04M | -4.63M | 1.32M |
|---|---|---|---|
| Mar 2023 | -13.57M | 28.10M | 255.78K |
| Jun 2023 | -13.66M | 27.57M | 256.73K |
| Sep 2023 | -13.95M | 33.85M | 933.36K |
AVITA Medical alternative data
| Aug 2023 | 126 |
|---|---|
| Sep 2023 | 126 |
| Oct 2023 | 126 |
| Nov 2023 | 126 |
| Dec 2023 | 126 |
| Jan 2024 | 126 |
| Feb 2024 | 126 |
| Mar 2024 | 207 |
| Apr 2024 | 207 |
| May 2024 | 207 |
| Jun 2024 | 207 |
| Jul 2024 | 207 |
AVITA Medical other data
6.57%
-11.07%
of RCEL is owned by hedge funds
37
-15
1.64M
-2.76M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 1250 | 0 |
| May 2024 | 1000 | 0 |
| Dec 2024 | 975 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | O'TOOLE DAVID D officer: CFO | Common Stock | 500 | $12.4 | $6,200 | ||
Purchase | O'TOOLE DAVID D officer: CFO | Common Stock | 475 | $12.53 | $5,952 | ||
Purchase | O'TOOLE DAVID D officer: CFO | Common Stock | 500 | $8.6 | $4,300 | ||
Purchase | O'TOOLE DAVID D officer: CFO | Common Stock | 500 | $9.2 | $4,600 | ||
Purchase | O'TOOLE DAVID D officer: CFO | Common Stock | 250 | $17.43 | $4,358 | ||
Purchase | O'TOOLE DAVID D officer: CFO | Common Stock | 1,000 | $17.38 | $17,380 | ||
Sale | CORBETT JAMES director, officer: CEO | Common | 1,445 | $13.29 | $19,204 | ||
Sale | COOK JEREMY CURNOCK director | Common | 2,500 | $12.49 | $31,225 | ||
Sale | COOK JEREMY CURNOCK director | Common | 2,518 | $12.27 | $30,896 | ||
Purchase | O'TOOLE DAVID D officer: CFO | Common Stock | 950 | $12.45 | $11,828 |
| Quarter | Transcript |
|---|---|
| Q1 2024 13 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 22 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 9 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 10 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Dr. Michael S. Perry D.V.M., DVM, FACVPT, Ph.D. (1959) Chief Executive Officer, Pres & Executive Director | $1,060,000 |
| Ms. Erin Liberto (1974) Chief Commercial Officer | $515,270 |
| Mr. Andrew Quick (1971) Chief Technology Officer | $491,700 |
| Ms. Donna Shiroma (1962) Gen. Counsel & Sec. | $473,710 |
Mr. Michael Bria Holder MBA (1963) Chief Financial Officer | $464,300 |
| Ms. Kathy M. McGee (1966) Chief Operating Officer | $398,970 |
Undercovered Dozen: Natera, Lloyds Banking Group, Eaton, Primoris Services +
AVITA Medical Just Tripled Its TAM In The Burn Market
AVITA Medical Positioned For Stellar 2024 With Skin Repair Innovation Momentum
AVITA Medical's 'Better Mousetrap' Rapidly Gaining Traction In Skin Repair
AVITA Medical: At A Crossroads
AVITA Medical: Experienced CEO Taking The Helm As Expansion Opportunities Await
Avita: Micro-Cap With Big Time Approvals On Near Horizon
AVITA Medical Gains FDA Expanded Labels In 'Better Mousetrap' Burn Treatment
AVITA: Recell's Growing Upside
-
What's the price of AVITA Medical stock today?
One share of AVITA Medical stock can currently be purchased for approximately $4.94.
-
When is AVITA Medical's next earnings date?
Unfortunately, AVITA Medical's (RCEL) next earnings date is currently unknown.
-
Does AVITA Medical pay dividends?
No, AVITA Medical does not pay dividends.
-
How much money does AVITA Medical make?
AVITA Medical has a market capitalization of 306.22M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 254.49% to 50.56M US dollars. AVITA Medical made a loss 39.17M US dollars in net income (profit) last year or -$0.22 on an earnings per share basis.
-
What is AVITA Medical's stock symbol?
AVITA Medical, Inc. is traded on the NASDAQ under the ticker symbol "RCEL".
-
What is AVITA Medical's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of AVITA Medical?
Shares of AVITA Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are AVITA Medical's key executives?
AVITA Medical's management team includes the following people:
- Dr. Michael S. Perry D.V.M., DVM, FACVPT, Ph.D. Chief Executive Officer, Pres & Executive Director(age: 66, pay: $1,060,000)
- Ms. Erin Liberto Chief Commercial Officer(age: 51, pay: $515,270)
- Mr. Andrew Quick Chief Technology Officer(age: 54, pay: $491,700)
- Ms. Donna Shiroma Gen. Counsel & Sec.(age: 63, pay: $473,710)
- Mr. Michael Bria Holder MBA Chief Financial Officer(age: 62, pay: $464,300)
- Ms. Kathy M. McGee Chief Operating Officer(age: 59, pay: $398,970)
-
How many employees does AVITA Medical have?
As Jul 2024, AVITA Medical employs 207 workers.
-
When AVITA Medical went public?
AVITA Medical, Inc. is publicly traded company for more then 13 years since IPO on 14 May 2012.
-
What is AVITA Medical's official website?
The official website for AVITA Medical is avitamedical.com.
-
Where are AVITA Medical's headquarters?
AVITA Medical is headquartered at 28159 Avenue Stanford, Valencia, CA.
-
How can i contact AVITA Medical?
AVITA Medical's mailing address is 28159 Avenue Stanford, Valencia, CA and company can be reached via phone at +66 13 679 170.
AVITA Medical company profile:
AVITA Medical, Inc.
avitamedical.comExchange:
NASDAQ
Full time employees:
207
Industry:
Medical - Devices
Sector:
Healthcare
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.
28159 Avenue Stanford
Valencia, CA 91355
Valencia, CA 91355
CIK: 0001762303
ISIN: US05380C1027
CUSIP: 05380C102
